| Anthony L Rostain, MD | |
|
3 Cooper Plz Rm 307, Camden, NJ 08103-1438 | |
| (856) 342-2328 | |
| Not Available |
| Full Name | Anthony L Rostain |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 44 Years |
| Location | 3 Cooper Plz Rm 307, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760418446 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cmc Psychiatric Associates Pc | 2264401686 | 26 |
News Archive
Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin.
InSite Vision Incorporated today announced that patient enrollment has been completed in the DOUBle Phase 3 clinical trial of AzaSite Plus (ISV-502) and DexaSite (ISV-305) for the treatment of blepharitis.
Despite a promise three years ago to fix on-going problems, the American Red Cross is in trouble again for violating blood-safety laws.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.
› Verified 5 days ago
| Entity Name | Cmc Psychiatric Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982646634 PECOS PAC ID: 2264401686 Enrollment ID: O20041001000003 |
News Archive
Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin.
InSite Vision Incorporated today announced that patient enrollment has been completed in the DOUBle Phase 3 clinical trial of AzaSite Plus (ISV-502) and DexaSite (ISV-305) for the treatment of blepharitis.
Despite a promise three years ago to fix on-going problems, the American Red Cross is in trouble again for violating blood-safety laws.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony L Rostain, MD 1 Federal St # 200, Camden, NJ 08103-1088 Ph: (856) 356-4924 | Anthony L Rostain, MD 3 Cooper Plz Rm 307, Camden, NJ 08103-1438 Ph: (856) 342-2328 |
News Archive
Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin.
InSite Vision Incorporated today announced that patient enrollment has been completed in the DOUBle Phase 3 clinical trial of AzaSite Plus (ISV-502) and DexaSite (ISV-305) for the treatment of blepharitis.
Despite a promise three years ago to fix on-going problems, the American Red Cross is in trouble again for violating blood-safety laws.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine Hydrochloride Extended-release Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base), the generic version of Wyeth's Effexor XR Capsules, which are used in the treatment of major depressive disorder and social anxiety disorder.
› Verified 5 days ago
Dr. Thomas Denton Demark, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 | |
Nicholas Matthew Adamo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 800-826-6737 | |
Pamela Szeeley, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-968-7433 | |
John E Bevilacqua, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 320, Camden, NJ 08103 Phone: 856-616-1337 | |
Dr. Michael H Goodman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 200, Camden, NJ 08103 Phone: 856-342-2001 Fax: 856-968-2499 | |
Yingcheng Xu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 307, Camden, NJ 08103 Phone: 856-342-2328 | |
Teresa J Humaran, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 |